CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 13,176 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 103,645 shares (option exercise)
- 4 Exercise or conversion Chief Development Officer acquired 117,113 shares (option exercise)
- 4 Open-market buy Director bought 6,487 shares at $15.42 ($100,030)
- 4 Open-market buy FMR LLC bought 50,000 shares at $16.00 ($800,000)
- 4 Conversion Director acquired 160,416 shares (conversion)
- 4 Conversion Director acquired 93,048 shares (conversion)
- 4 Open-market buy Director bought 50,000 shares at $16.00 ($800,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 14 · 269 filings